• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENDOLOGIX SANTA ROSA OVATION IX; ILIAC LIMB

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENDOLOGIX SANTA ROSA OVATION IX; ILIAC LIMB Back to Search Results
Model Number TV-IL1418120-J
Device Problems Improper or Incorrect Procedure or Method (2017); Unintended Movement (3026)
Patient Problem Failure of Implant (1924)
Event Date 04/18/2022
Event Type  Injury  
Event Description
The patient was being treated for an abdominal aortic aneurysm (aaa) with the alto stent graft system.Approximately one (1) year post initial procedure, routine follow-up identified a type ib endoleak from the right iliac limb.Reportedly at the initial implant, coverage was very short (less than 10mm).The ovation ix iliac limb has retracted into the aneurysm sac.Reintervention is to be scheduled.The patient is doing well.
 
Manufacturer Narrative
The devices involved in this event will not be returned for evaluation and remain implanted in the patient.Patient medical records and imaging studies will be requested for further evaluation by a clinical specialist.If additional information pertinent to the incident is obtained, a follow-up report will be submitted.Device remains implanted.
 
Event Description
The patient was being treated for an abdominal aortic aneurysm (aaa) with the alto stent graft system.Approximately one (1) year post initial procedure, routine follow-up identified a type ib endoleak from the right iliac limb.Reportedly at the initial implant, coverage was very short (less than 10mm).The ovation ix iliac limb has retracted into the aneurysm sac.Reintervention is to be scheduled.The patient is doing well.After the initial procedure, additional information was received reporting that reintervention was performed with the implant of an ovation ix iliac limb.The type ib endoleak was successfully resolved.The patient was reported to be doing well post procedure.
 
Manufacturer Narrative
The reported adverse event/incident was investigated in alignment with endologix operating procedures and work instructions.Where possible, it is endologix practice to make at least three good faith efforts to retrieve a reported adverse event/incident related device as well as medical records and medical imaging.An evaluation of the manufacturing record was completed.A review of the part number/lot number combination needed for device identification shows the device to have been properly manufactured and released in accordance with the device master record.An evaluation of the device could not be completed.The device was not returned to endologix for evaluation because it remains implanted.A clinical evaluation of the adverse event/incident was completed.An examination of medical records and/or medical imaging received by endologix shows the type ib endoleak, cranial migration of the right iliac limb, and additional endovascular procedure is confirmed.This is consistent with the reported adverse event/incident.Device, procedure or anatomy relatedness of this event could not be determined.However, it was reported that initial right iliac limb coverage was less than 10mm and this likely contributed to implant migration and type ib endoleak.The final patient status was discharged home on the first post operative day.No additional investigation of this reported adverse event/incident is planned.However, should additional information relevant to the investigation outcome become available, a follow-up report will be submitted.Endologix will continue to monitor this and similar adverse events/incidents.B2: outcomes attributed to ae - updated; b5: describe event or problem - updated; g3: awareness date ¿ updated; h6: health effect - impact code ¿ remove code 4614; h6: investigation finding codes - remove code 3233; h6: investigation conclusion codes - remove code 11.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OVATION IX
Type of Device
ILIAC LIMB
Manufacturer (Section D)
ENDOLOGIX SANTA ROSA
3910 brickway blvd
santa rosa CA 95403
Manufacturer (Section G)
ENDOLOGIX SANTA ROSA
3910 brickway blvd
,
santa rosa CA 95403
Manufacturer Contact
gary kirchgater
3910 brickway blvd
,
santa rosa, CA 95403
8009832284
MDR Report Key14210122
MDR Text Key290087953
Report Number3008011247-2022-00040
Device Sequence Number1
Product Code MIH
UDI-Device IdentifierM701TVIL1418120J1
UDI-Public+M701TVIL1418120J1/$$3231028FS10282021G
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P120006
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Health Professional,Company Representative
Reporter Occupation Physician
Remedial Action Other
Type of Report Initial,Followup
Report Date 04/20/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/26/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date10/28/2023
Device Model NumberTV-IL1418120-J
Device Catalogue NumberTV-IL1418120-J
Device Lot NumberFS102820-21
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/22/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured11/20/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
ALTO MAIN BODY (LN FS071720-01),; OVATION PRIME FILL POLYMER (LN FF091520-01).; OVATION X ILIAC LIMB (LN FS090120-21),; OVATION X ILIAC LIMB (LN FS102820-23),
Patient Outcome(s) Required Intervention; Other;
Patient Age69 YR
-
-